[Factor VII and protein-C markers are no prognostic indicators in acute coronary heart disease]

O Friesewinkel1, G A Marbet, R Ritz

  • 1Gerinnungs- und Fibrinolyselaboratorium, Abteilung für Intensivmedizin, DIM, Kantonsspital Basel.

Schweizerische Medizinische Wochenschrift
|January 23, 1993
PubMed

Insights

Fibrinogen, factor VII, and protein C levels do not predict outcomes in acute coronary heart disease (aCHD). Assays for these factors lack prognostic relevance in aCHD patient subgroups.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Biochemistry

Context:

  • Fibrinogen and factor VII are established risk factors for cardiovascular disease.
  • Previous research suggested a link between factor VII coagulant activity and acute coronary heart disease (aCHD) manifestations.
  • The prognostic significance of these factors in different aCHD clinical evolutions requires further investigation.

Purpose:

  • To prospectively evaluate the prognostic relevance of fibrinogen, factor VII (VII:C, VII:am, VII:Ag), and protein C (PCf, PC:Ag) in patients with acute coronary heart disease (aCHD).
  • To determine if these hemostatic markers can differentiate between prognostically distinct aCHD subgroups: unstable angina (UA), myocardial infarction without heart failure (M-I), and myocardial infarction with heart failure (M-II).

Summary:

  • A prospective study compared hemostatic markers in 76 aCHD patients (26 UA, 23 M-I, 27 M-II) and 27 controls.
  • No significant differences were found in fibrinogen, factor VII, or protein C levels between control and aCHD groups or their subgroups.
  • While the VII:C/VII:Ag ratio was elevated in aCHD patients, it did not distinguish between prognostically different aCHD subgroups.

Impact:

  • This study indicates that routine measurements of fibrinogen, factor VII, and protein C lack prognostic value in acute coronary heart disease.
  • The findings suggest that these specific hemostatic markers are not useful for predicting clinical outcomes or stratifying risk within different aCHD presentations.
  • Further research may be needed to identify other biomarkers with prognostic relevance in cardiovascular disease management.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...